DNase is a prognostic marker in liver cancer patients receiving transarterial chemoembolization therapy

Nikolaus Kohles, Dorothea Nagel, Dietrich Jüngst, Petra Stieber, Stefan Holdenrieder

Research output: Contribution to journalArticlepeer-review

3 Scopus citations
Original languageEnglish
Pages (from-to)80-83
Number of pages4
JournalInternational Journal of Clinical Pharmacology and Therapeutics
Issue number1
StatePublished - Jan 2013
Externally publishedYes


  • DNase
  • Liver cancer
  • TACE therapy

Cite this